A quick note: With the 280+ comments I received on my piece published over the weekend about selling a portion of your Apple (NASDAQ:AAPL) stock, I wanted to further clarify my position as the context is important in reading this piece. Unfortunately, many I fear read the title and glossed over the article before commenting, albeit insightful and informative commentary.
My main thesis was: generate a handsome profit by selling a portion (1% up to whatever you are comfortable with) of your current Apple position, because with the current Q1 numbers and future uncertainty in the hardware world, there are more undervalued stocks out there to "seek alpha."
Unfortunately the title, "Consider Selling a Portion of Your Apple Stock to Capture Gains and Reinvest in Undervalued Sectors for Higher Probability of Alpha" - was not fit to print. And because I'm all about equal opportunity, I've written a strategy to make money off naysayers like me! Now onto your regularly scheduled programming…
Hot Undervalued Stocks To Invest In 2019: Oxford Industries Inc.(OXM)
Advisors' Opinion:- [By Max Byerly]
Oxford Industries (NYSE:OXM) announced its quarterly earnings results on Wednesday. The textile maker reported $1.83 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.83, Bloomberg Earnings reports. The company had revenue of $302.60 million for the quarter, compared to analysts’ expectations of $306.12 million. Oxford Industries had a net margin of 6.30% and a return on equity of 15.17%. Oxford Industries’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.44 EPS. Oxford Industries updated its Q3 guidance to $0.10-0.20 EPS and its FY19 guidance to $4.45-4.65 EPS.
- [By Motley Fool Staff]
Oxford Industries (NYSE:OXM) Q1 2018 Earnings Conference CallJun. 12, 2018 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
GW&K Investment Management LLC raised its stake in Oxford Industries (NYSE:OXM) by 1.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 357,935 shares of the textile maker’s stock after acquiring an additional 4,019 shares during the period. GW&K Investment Management LLC owned approximately 2.13% of Oxford Industries worth $26,688,000 as of its most recent SEC filing.
Hot Undervalued Stocks To Invest In 2019: Can-Fite Biopharma Ltd(CANF)
Advisors' Opinion:- [By Max Byerly]
CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.
- [By Shane Hupp]
Media headlines about Can-Fite Biopharma (NASDAQ:CANF) have trended positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.6620747072303 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
- [By Shane Hupp]
Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Hot Undervalued Stocks To Invest In 2019: Acacia Research Corporation(ACTG)
Advisors' Opinion:- [By Stephan Byrd]
Acacia Research Corp (NASDAQ:ACTG) reached a new 52-week low during trading on Wednesday . The company traded as low as $3.00 and last traded at $3.06, with a volume of 4160 shares. The stock had previously closed at $3.15.
- [By Shane Hupp]
Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
- [By Logan Wallace]
These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
Get Acacia Research alerts: Acacia Research to Release Second Quarter Financial Results (finance.yahoo.com) Acacia Research Announces Changes to Board of Directors (finance.yahoo.com) Acacia Research: Miso Robotics’ Kitchen Assistant, Flippy, May Be Worth Flipping Over (seekingalpha.com) Acacia Research (ACTG) Scheduled to Post Quarterly Earnings on Friday (americanbankingnews.com)A number of research analysts have weighed in on ACTG shares. Zacks Investment Research upgraded shares of Acacia Research from a “sell” rating to a “hold” rating in a research report on Tuesday, July 3rd. ValuEngine downgraded shares of Acacia Research from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd.
- [By Stephan Byrd]
Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.
Hot Undervalued Stocks To Invest In 2019: Collegium Pharmaceutical, Inc.(COLL)
Advisors' Opinion:- [By Logan Wallace]
Collegium Pharmaceutical (NASDAQ:COLL) – Piper Jaffray lowered their FY2021 EPS estimates for shares of Collegium Pharmaceutical in a note issued to investors on Wednesday, May 9th. Piper Jaffray analyst D. Amsellem now forecasts that the specialty pharmaceutical company will post earnings per share of $2.06 for the year, down from their previous forecast of $2.32. Piper Jaffray has a “Buy” rating and a $33.00 price target on the stock.
- [By Shane Hupp]
Los Angeles Capital Management & Equity Research Inc. acquired a new position in Collegium Pharmaceutical Inc (NASDAQ:COLL) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 16,100 shares of the specialty pharmaceutical company’s stock, valued at approximately $384,000.
- [By Todd Campbell]
Depomed is in the middle of a restructuring of its business that includes out-licensing its lead drug, Nucynta. In December, Collegium (NASDAQ:COLL) cut a licensing deal for Nucynta that guarantees Depomed $135 million in annual royalties, paid quarterly in arrears, for four years. If sales exceed $233 million per year, then Collegium Pharmaceutical will also pay Depomed a double-digit royalty on top of the minimum license fee. After four years, Depomed will receive double-digit royalties on all net Nucynta sales.
- [By Joseph Griffin]
State Board of Administration of Florida Retirement System acquired a new stake in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,174 shares of the specialty pharmaceutical company’s stock, valued at approximately $260,000.
- [By Max Byerly]
Get a free copy of the Zacks research report on Collegium Pharmaceutical (COLL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Collegium Pharmaceutical Inc (NASDAQ:COLL) shares were up 6.5% during trading on Friday . The stock traded as high as $15.15 and last traded at $14.79. Approximately 511,962 shares traded hands during trading, an increase of 20% from the average daily volume of 425,396 shares. The stock had previously closed at $13.89.
Hot Undervalued Stocks To Invest In 2019: CLP Holdings Ltd (2)
Advisors' Opinion:- [By ]
Read more: Erdogan’s Road Map Out of Market Meltdown Is Full of U-Turns (2)
Below are some of the highlights on the treasury’s road map, which Albayrak will flesh out during a briefing at 11 a.m. local time on Friday:
- [By ]
Long-Short sub-strategy funds gained 1.24 percent in May, underperforming the S&P 500 by 117 basis points.
NOTE: Go to HFND and select option 3 to see the Bloomberg Hedge Fund Database Snapshot for more details on hedge fund performanceNOTE: See HFS to screen for specific hedge fundsNOTE: All data are total return including reinvested dividends. May data are the most recent available. June returns become available around July 12.NOTE: “Equity Hedge” refers to a Bloomberg-created term for strategies where the largest subset of funds is L/S Equity and Long-Biased hedge fundsRELATED: Here are how some hedge funds performed last monthJune 11: Hedge Fund With 69% Return Sees More to Come From Oil RecoveryJune 8: Macro Hedge Funds Cashed In on Mess From Italy, Trade Wars (2)June 7: BlackRock’s Biggest Hedge Fund Bleeds Talent as Deputy CIOs Exit— With assistance by Brian Pennisi
- [By ]
(1) Cash flow adjusted by working capital and, in the case of Aramco, $21.4 billion owed to the company from the government (2) Production for all companies is the annual average for 2016, the most recent figures available for Aramco
No comments:
Post a Comment